Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation - Test2 - elhamkhani - TriplyDB

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

http://www.wikidata.org/entity/Q34452574

about

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.Retrospective Analysis of Posaconazole Suspension Dosing Strategies in a Pediatric Oncology Population: Single-Center Experience.Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.Posaconazole Plasma Monitoring in Immunocompromised Children.Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany.Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.Pediatric Invasive Aspergillosis.Invasive Aspergillosis in Children: Update on Current Guidelines

P2860

Q26782472-829CD04C-32B1-490A-8407-D1CF87B52960 Q27009221-2329490C-82DF-4AF2-9A80-B02B33C84777 Q27025299-9C6596F4-5B5A-4FDB-9412-FCC8F24C27DC Q35589175-826706E2-7559-42B1-A978-6EEE12929F8A Q37636223-A55E701B-2ED9-465C-8AA5-C15EF584A38E Q38284455-FF27E211-FDE0-49BB-92BA-E7B8595891DD Q38321383-25E315D9-87D1-4835-BFE4-D69D12EC678F Q38353420-3D3DE4FA-EA55-450E-A842-7EB19245A308 Q39041116-D9F178BA-2410-41B5-9874-81DB087974CD Q40043031-82A4CCD8-807C-4030-8E69-1919EF21E7BA Q40309090-A83E9D81-A3AD-4B57-82E6-9734EF6FAE65 Q40337289-D529E8B2-8349-4769-8880-DB9925A18EC3 Q40413232-CCBEFD44-E3A0-40B9-AC8B-09019BAD3121 Q40517272-9105B9BB-8BD9-45DD-B5B1-4C2BF3BFC0F0 Q41676735-2FDD9E69-8EBC-41D3-83E7-1C126DF47AF2 Q48118247-0F658E64-FA36-4695-A534-07C93D523C75 Q49612998-D7867560-BC99-4E80-B361-10F3905B9FB0 Q58775551-ED3184C3-6F5F-4658-BD5E-60E6D0C214F5

P2860

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

http://www.wikidata.org/entity/Q34452574

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Analysis of posaconazole as or ...... neic stem cell transplantation

@ast

Analysis of posaconazole as or ...... neic stem cell transplantation

@en

Analysis of posaconazole as or ...... neic stem cell transplantation

@nl

type

label

Analysis of posaconazole as or ...... neic stem cell transplantation

@ast

Analysis of posaconazole as or ...... neic stem cell transplantation

@en

Analysis of posaconazole as or ...... neic stem cell transplantation

@nl

prefLabel

Analysis of posaconazole as or ...... neic stem cell transplantation

@ast

Analysis of posaconazole as or ...... neic stem cell transplantation

@en

Analysis of posaconazole as or ...... neic stem cell transplantation

@nl

P1433

Q34452574-09CB0474-6727-44C4-87B8-2FF9CC5D7276

P1476

Q34452574-352A3C4A-522A-468F-B2BE-D5B111F87F11

P2093

Q34452574-19863A39-132D-4D43-80F5-EB1E8B5DA4CB

Q34452574-35F8FE89-9B86-43B8-A5FB-89D67A7C9A7A

Q34452574-437FEC8D-2AB9-4F97-AE6F-22376750B82B

Q34452574-4D8B5FF0-AD7F-423B-9500-3037F09D4DAE

Q34452574-7F9FE105-2F1A-4322-86F2-F4AF0A7C3C14

Q34452574-A82D6CD6-B8AB-467F-9606-DFD028D0A417

Q34452574-B53E96BB-20F7-4F12-83ED-5F886DFD8D0E

Q34452574-DA87E7C9-C020-4219-8864-6A0BB609C7A3

Q34452574-E2CDEF81-91CE-4C0F-9B73-195D0F5B74A7

P2860

Q34452574-11EA0DD2-AFC0-43A9-BA2B-131A141D74AD

Q34452574-2F96109D-214C-4E44-BB9E-30A009624C65

Q34452574-39739C13-52EF-4255-8EE6-FC22F1597F0F

Q34452574-3F519BEA-8F83-4531-8732-FF53F1728B14

Q34452574-41317E7E-FC23-42B2-BBED-DE6868AF44ED

Q34452574-446AA673-B9E0-4847-B2E5-394A1F55F96D

Q34452574-44E68AD2-80DE-40AD-B366-1765047BCB79

Q34452574-5394C64F-C4FD-413B-A650-A4F7095D1841

Q34452574-577CCE88-EBCD-417E-AE2C-8F70E9DFBED3

Q34452574-5C32D7F0-BF0D-44E8-AE46-177A391C8472

P2888

Q34452574-26049262-2A03-46AB-B135-5CABD360F31F

P304

Q34452574-E41D318C-37E2-4FAE-8100-98C35A7130AD

P31

Q34452574-87526ACF-2775-4F34-804F-F65F9165D691

P356

Q34452574-0F7C5479-C4A7-48C4-9F40-D9522124E2F2

P478

Q34452574-41AAF465-BAC3-49CD-9FF1-3D231683652E

P577

Q34452574-95C64037-858C-46E0-B786-7012FDA779D5

P5875

Q34452574-4486CA44-4CAB-4482-97B9-064252BD758F

P6179

Q34452574-5D63A39B-2409-44D6-9A57-190248692426

P698

Q34452574-04FDAD96-DE59-4D95-B071-6F207ABCE23D

P932

Q34452574-E03984C3-14AE-41BB-B198-171CB2BF9C85

P356

1471-2334-12-263

P1433

BMC Infectious Diseases

P1476

Analysis of posaconazole as or ...... neic stem cell transplantation

@en

P2093

Annika Erbacher

http://www.w3.org/2001/XMLSchema#string

Astrid Kimmig

http://www.w3.org/2001/XMLSchema#string

Carl-Philipp Schwarze

http://www.w3.org/2001/XMLSchema#string

Carsten Müller

http://www.w3.org/2001/XMLSchema#string

Ingo Müller

http://www.w3.org/2001/XMLSchema#string

Michaela Döring

http://www.w3.org/2001/XMLSchema#string

Pascal-David Johann

http://www.w3.org/2001/XMLSchema#string

Peter Lang

http://www.w3.org/2001/XMLSchema#string

Rupert Handgretinger

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

Aspergillosis case-fatality rate: systematic review of the literature.

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.

P2888

1471-2334-12-263

P304

263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-12-263

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232526709

http://www.w3.org/2001/XMLSchema#string

P6179

1008165039

http://www.w3.org/2001/XMLSchema#string

P698

23082876

http://www.w3.org/2001/XMLSchema#string

P932

3514296

http://www.w3.org/2001/XMLSchema#string